High Cholesterol. Unmasking the Silent Culprit.
In today's fast-paced world, maintaining a healthy lifestyle is of paramount importance. Among various health concerns, high cholesterol levels have emerged as a prevalent issue affecting millions of individuals worldwide.
This blog aims to shed light on the age at which high cholesterol can develop, its gender distribution, genetic predisposition, and how DNA testing can assist in identifying the risk factors associated with it.
Age of Onset
High cholesterol levels are not confined to a particular age group.
While it is often associated with older individuals, it is increasingly being observed in younger populations due to unhealthy dietary choices and sedentary lifestyles.
According to a study published in the Journal of the American College of Cardiology (Grundy et al., 2018), the prevalence of high cholesterol tends to increase with age, with a higher risk for both men and women as they reach middle age and beyond.
However, it is important to note that the development of high cholesterol can occur at any age.
Gender Distribution
When it comes to the distribution of high cholesterol, both males and females are equally susceptible.
Historically, men have been considered more prone to developing high cholesterol due to hormonal differences and lifestyle factors.
However, recent research, such as a study conducted by Pambianco et al. (2020) and published in the Journal of Clinical Lipidology, suggests that the prevalence of high cholesterol among women is steadily rising.
Factors such as hormonal changes during menopause and lifestyle choices contribute to this shift in gender distribution.
Genetic Predisposition
Genetics plays a significant role in determining an individual's susceptibility to high cholesterol.
Research has identified several genes that influence cholesterol metabolism, including the APOB, LDLR, and PCSK9 genes.
A study published in Circulation: Genomic and Precision Medicine by Talmud et al. (2019) revealed that genetic variants in these genes can increase the risk of high cholesterol and its associated complications.
Individuals with a family history of high cholesterol are more likely to be genetically predisposed to the condition.
Role of DNA Testing
Advancements in genetic research have enabled the development of DNA testing as a valuable tool in assessing an individual's predisposition to high cholesterol.
DNA testing, particularly through techniques like genetic sequencing, can identify specific genetic variants associated with high cholesterol.
By analyzing an individual's DNA, healthcare professionals can gain insights into their genetic risk profile and make personalised recommendations for preventive measures.
Additionally, DNA testing can help in identifying genetic disorders that contribute to high cholesterol, such as familial hypercholesterolemia (FH).
FH is an inherited condition characterised by abnormally high levels of low-density lipoprotein (LDL) cholesterol, often leading to premature cardiovascular disease.
Early identification of FH through DNA testing allows for timely interventions and management strategies to reduce the risk of heart disease.
High cholesterol is a global health concern affecting individuals across various age groups and both genders.
While age and lifestyle choices play a crucial role, genetic factors also contribute significantly to an individual's predisposition to high cholesterol.
DNA testing has emerged as a valuable tool for identifying genetic risk factors and enabling personalised preventive measures.
By combining lifestyle modifications, regular screenings, and genetic insights, individuals can proactively manage their cholesterol levels and reduce the risk of cardiovascular complications.
Sources:
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., Goldberg, R., Heidenreich, P. A., Hlatky, M. A., Jones, D. W., Lloyd-Jones, D., Lopez-Pajares, N., Ndumele, C. E., Orringer, C. E., Peralta, C. A., ... & Sperling, L. (2018). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Journal of the American College of Cardiology, 73(24), e285-e350.
Pambianco, V., Banegas, J. R., Segura, J., Böhm, M., Redon, J., Kolloch, R. E., ... & Ruilope, L. M. (2020). Incidence and predictors of high low-density lipoprotein cholesterol (LDL-C) in high-risk patients treated with lipid-lowering therapy: Results from the lipid treatment assessment project (L-TAP). Journal of Clinical Lipidology, 14(2), 190-199.
Talmud, P. J., Shah, S., Whittall, R., Futema, M., Howard, P., Cooper, J. A., ... & Humphries, S. E. (2019). Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case–control study. Circulation: Genomic and Precision Medicine, 12(10), e002492.
* Please note that at Parkside Designs Art we are not doctors or scientists. The information in this blog is informative only. We accept no liability in any form for the information provided.
Thanks for reading our blog. We hope it's been beneficial for you. If you think it could benefit someone you know, then please feel free to share.
Kim - Personal Assistant To The Creative Director - Josh